Sustained virological response: a milestone in the treatment of chronic hepatitis C
Publication Type:
Journal Article
Authors:
Morisco, F.;
Granata, R.;
Stroffolini, T.;
Guarino, M.;
Donnarumma, L.;
Gaeta, L.;
Loperto, I.;
Gentile, I.;
Auriemma, F.;
Caporaso, N.Source:
World J Gastroenterol, Volume 19, Issue 18, p.2793-2798 (2013)
Keywords:
Adult,
Aged,
Antibodies,
Antiviral Agents,
Biological Markers,
Biopsy,
blood,
Carcinoma,
complications,
Death,
diagnosis,
drug effects,
drug therapy,
Drug Therapy,Combination,
eradication,
Female,
Fibrosis,
Follow-Up Studies,
genetics,
growth & development,
HCV,
Hepacivirus,
hepatitis,
Hepatitis C,
Hepatitis C Antibodies,
hepatitis C virus,
Hepatitis C,Chronic,
Hospitals,University,
Humans,
immunology,
Incidence,
Infection,
interferon,
Interferon-alpha,
Italy,
Liver,
Liver Cirrhosis,
Male,
methods,
Middle Aged,
Mortality,
Patients,
peginterferon,
peginterferon alfa-2b,
pegylated,
Polyethylene Glycols,
Prognosis,
Proteins,
Recombinant Proteins,
Recurrence,
Remission Induction,
Ribavirin,
Risk,
Rna,
Rna,Viral,
Serum,
Survival,
Survival Rate,
SVR,
therapeutic use,
therapy,
Time Factors,
treatment,
Treatment Outcome,
Viral Load,
virology,
Young Adult
Notes:
PMC3653153
